Boston Beer Posts Q2 Profit of $4.96/Share, Lifts Full-Year EPS Outlook on Leaner Spending
SAM is trading near its 52-week low of $158.68 (12% above the low).
Summary
Boston Beer posted Q2 GAAP EPS of $4.96 and raised its full-year non-GAAP EPS outlook to $8.50–$10.50, driven by cost discipline and a favorable litigation adjustment, while volumes continued to decline.
Key Events · Earnings and Guidance · SAM
-
Q2 Earnings Beat with Litigation Boost
GAAP diluted EPS of $4.96 included a $1.31 per share favorable litigation adjustment; non-GAAP EPS was $3.65. Net revenue fell 3.3% to $568.3 million on a 6% depletion decline.
-
Full-Year Guidance Raised
Non-GAAP EPS guidance raised to $8.50–$10.50 (from $8.50–$10.50) and GAAP loss narrowed to ($6.23)–($4.23) from ($7.02)–($5.02). Advertising spend growth cut to $0–$20M from $20–$40M, and capex lowered to $60–$80M.
-
Supplier Litigation Update
Q2 included a $19.4M litigation reduction (favorable pre-judgment interest adjustment). Year-to-date litigation expense totals $192.6M ($175.5M judgment + interest). Company denies breach and will appeal.
-
Strong Balance Sheet and Buybacks
Ended Q2 with $265.5M cash, no debt. Repurchased $54M in shares year-to-date; $174M remains on $1.6B buyback authorization.
Analysis · SAM · Manufacturing
A solid second quarter saw Boston Beer deliver GAAP EPS of $4.96, helped by a $1.31 per share favorable litigation adjustment, while non-GAAP EPS reached $3.65. The company tightened its full-year GAAP loss forecast to ($6.23)–($4.23) from ($7.02)–($5.02) and raised non-GAAP EPS guidance to $8.50–$10.50, up from the prior $8.50–$10.50 range. Driving the improved outlook are lower planned advertising spend and capital expenditures, signaling disciplined cost management even as depletions fell 6%. The balance sheet remains robust with $265.5 million in cash and no debt, and the company continues to buy back shares aggressively, repurchasing $54 million year-to-date. While the ongoing supplier litigation remains a wildcard, the Q2 adjustment and management's intent to appeal offer some near-term relief.
At the time of this filing, SAM was trading at $178.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $158.68 to $264.46. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.